Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.
Journal: Blood cancer journal
Published: February 26, 2018
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 18, 2016
Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myeloma.
Journal: Current medical research and opinion
Published: March 19, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
Journal: Leukemia & lymphoma
Published: February 28, 2015
A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.
Journal: Cancer medicine
Published: February 18, 2014
Total cost comparison in relapsed/refractory multiple myeloma.
Journal: Journal of medical economics
Published: January 04, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026